Jessica J. Kandel to Infusions, Intravenous
This is a "connection" page, showing publications Jessica J. Kandel has written about Infusions, Intravenous.
Connection Strength
0.028
-
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2008 Jan 20; 26(3):399-405.
Score: 0.018
-
Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J Exp Med. 1999 Aug 02; 190(3):341-54.
Score: 0.010